The nation of Zimbabwe has rejected a major US healthcare agreement worth $367m (£272m) spanning five years due to Washington's request for sensitive information.
This rejection was revealed after a government memo dated December was leaked, revealing that President Emmerson Mnangagwa deemed the deal was "lopsided".
An official spokesperson later clarified that the United States was requesting biological samples for research and commercial purposes but was not willing to share the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate task of scaling back our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has appealed for continued dialogue to reach a agreement acceptable to all parties so the country's critical HIV programme can continue.
Broader Background
Zimbabwe's decision comes after a comparable case in Kenya, where a court halted a similar health funding agreement following legal challenges were filed about the safety of Kenyans' health data.
Since resuming office last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had overseen assistance for the American government, but Trump argued its expenditure was "wasteful" and his administration was pursuing government-to-government agreements to enhance openness and responsibility.
Based on reports, 16 nations in Africa have so far agreed to similar agreements, representing more than $18.3bn in new funding.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this collaboration could have provided significant benefits for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy through American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"Our nation was requested to surrender its genetic material and health information for a long time, without any equivalent promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Put simply, our country would supply the raw materials for medical research with no certainty that the final treatments would be available to our people if a future pandemic emerge."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one deals were disrupting structures already set up through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with future pandemics.
"This framework is designed to ensure that when a nation provides its data, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the funds to develop them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We are open to further dialogue with our American counterparts on how future co-operation might be structured in a way that respects the independence and interests of each country."
Health Experts Reaction
A leading public health body said it recognised the government's concerns, but urged that negotiations should continue since much of the nation's Aids initiatives relied on external financing.
"In cases where specific concerns exist, including those involving information security or implementation frameworks, these can frequently be resolved through technical clarification and negotiated safeguards," it added.
The situation underscores the complex tensions between accepting much-needed international aid and protecting national sovereignty in an ever more interconnected world.